Your browser doesn't support javascript.

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Home > Búsqueda > ()
XML
Imprimir Exportar

Formato de exportación:

Exportar

Email
Adicionar mas contactos
| |

The potential of methylxanthine-based therapies in pediatric respiratory tract diseases.

Oñatibia-Astibia, Ainhoa; Martínez-Pinilla, Eva; Franco, Rafael.
Respir Med; 112: 1-9, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26880379
Caffeine, theophylline and theobromine are the most known methylxanthines as they are present in coffee, tea and/or chocolate. In the last decades, a huge experimental effort has been devoted to get insight into the variety of actions that these compounds exert in humans. From such knowledge it is known that methylxanthines have a great potential in prevention, therapy and/or management of a variety of diseases. The benefits of methylxanthine-based therapies in the apnea of prematurity and their translational potential in pediatric affections of the respiratory tract are here presented.